CI
Cigna Group
Position levels
Currenttoday
USD 279.05
Buy <=wait / entry
USD 258.33
Trim >=take some off
USD 295.00
Thesis breakA material adverse regulatory action against PBM pricing or rebate practices, co...
-
Scenario-weighted conviction
| Probability | Score | Contribution | |
|---|---|---|---|
| Bull case | 37% | 100 / 100 | 37.0 |
| Base case | 47% | 62 / 100 | 29.1 |
| Bear case | 16% | 10 / 100 | 1.6 |
| Weighted conviction | 68 / 100 - BUY | ||
Top risks
- Acquisition of CarepathRx completed in February 2026
- Q2 2026 EPS beat of $0.18 ($7.78 actual vs $7.60 consensus) with 6.7% YoY revenue growth to $70.04B
- Raised 2026 EPS guidance to at least $30.35